Transformation elastodynamics and active exterior acoustic cloaking

This chapter consists of three parts. In the first part we recall the elastodynamic equations under coordinate transformations. The idea is to use coordinate transformations to manipulate waves propagating in an elastic material. Then we study the effect of transformations on a mass-spring network model. The transformed networks can be realized with "torque springs", which are introduced here and are springs with a force proportional to the displacement in a direction other than the direction of the spring terminals. Possible homogenizations of the transformed networks are presented, with potential applications to cloaking. In the second and third parts we present cloaking methods that are based on cancelling an incident field using active devices which are exterior to the cloaked region and that do not generate significant fields far away from the devices. In the second part, the exterior cloaking problem for the Laplace equation is reformulated as the problem of polynomial approximation of analytic functions. An explicit solution is given that allows to cloak larger objects at a fixed distance from the cloaking device, compared to previous explicit solutions. In the third part we consider the active exterior cloaking problem for the Helmholtz equation in 3D. Our method uses the Green's formula and an addition theorem for spherical outgoing waves to design devices that mimic the effect of the single and double layer potentials in Green's formula.Comment: Submitted as a chapter for the volume "Acoustic metamaterials: Negative refraction, imaging, lensing and cloaking", Craster and Guenneau ed., Springe

The ELFIN mission

The Electron Loss and Fields Investigation with a Spatio-Temporal Ambiguity-Resolving option (ELFIN-STAR, or heretoforth simply: ELFIN) mission comprises two identical 3-Unit (3U) CubeSats on a polar (∼93∘ inclination), nearly circular, low-Earth (∼450 km altitude) orbit. Launched on September 15, 2018, ELFIN is expected to have a >2.5 year lifetime. Its primary science objective is to resolve the mechanism of storm-time relativistic electron precipitation, for which electromagnetic ion cyclotron (EMIC) waves are a prime candidate. From its ionospheric vantage point, ELFIN uses its unique pitch-angle-resolving capability to determine whether measured relativistic electron pitch-angle and energy spectra within the loss cone bear the characteristic signatures of scattering by EMIC waves or whether such scattering may be due to other processes. Pairing identical ELFIN satellites with slowly-variable along-track separation allows disambiguation of spatial and temporal evolution of the precipitation over minutes-to-tens-of-minutes timescales, faster than the orbit period of a single low-altitude satellite (Torbit ∼ 90 min). Each satellite carries an energetic particle detector for electrons (EPDE) that measures 50 keV to 5 MeV electrons with Δ E/E 1 MeV. This broad energy range of precipitation indicates that multiple waves are providing scattering concurrently. Many observed events show significant backscattered fluxes, which in the past were hard to resolve by equatorial spacecraft or non-pitch-angle-resolving ionospheric missions. These observations suggest that the ionosphere plays a significant role in modifying magnetospheric electron fluxes and wave-particle interactions. Routine data captures starting in February 2020 and lasting for at least another year, approximately the remainder of the mission lifetime, are expected to provide a very rich dataset to address questions even beyond the primary mission science objective.Published versio

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Opportunistic Information Dissemination in Mobile Ad-hoc Networks: The Profit of Global Synchrony

The topic of this paper is the study of Information Dissemination in Mobile Ad-hoc Networks by means of deterministic protocols. We characterize the connectivity resulting from the movement, from failures and from the fact that nodes may join the computation at different times with two values, α and β, so that, within α time slots, some node that has the information must be connected to some node without it for at least β time slots. The protocols studied are classified into three classes: oblivious (the transmission schedule of a node is only a function of its ID), quasi-oblivious (the transmission schedule may also depend on a global time), and adaptive. The main contribution of this work concerns negative results. Contrasting the lower and upper bounds derived, interesting complexity gaps among protocolclasses are observed. More precisely, in order to guarantee any progress towards solving the problem, it is shown that β must be at least n − 1 in general, but that β ∈ Ω(n 2 / log n) if an oblivious protocol is used. Since quasi-oblivious protocols can guarantee progress with β ∈ O(n), this represents a significant gap